Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Coagulation Abnormalities
100%
Tissue Plasminogen Activator (t-PA)
100%
Atypical Hemolytic Uremic Syndrome (aHUS)
100%
Plasminogen Activator inhibitor-1 (PAI-1)
50%
Plasma Concentration
33%
D-dimer
33%
Escherichia Coli O157
33%
Thrombocytopenia
16%
Renal Injury
16%
Renal Function
16%
Thrombotic Complications
16%
Illness
16%
Linear Regression Model
16%
Thrombin Generation
16%
β2-microglobulin (β2-MG)
16%
Thrombogenesis
16%
Fibrinolysis
16%
N-acetylglucosaminidase
16%
Clotting Cascade
16%
Prothrombin Fragment 1 + 2
16%
Plasmin-antiplasmin Complex
16%
Azotemia
16%
Urinary Concentration
16%
Squared Correlation Coefficient
16%
Uncomplicated Infection
16%
Medicine and Dentistry
Tissue Plasminogen Activator
100%
Atypical Hemolytic Uremic Syndrome
100%
Plasminogen Activator Inhibitor-1
50%
Diseases
33%
Infection
33%
D-Dimer
33%
Escherichia Coli O157
33%
Thrombocytopenia
16%
Thrombin
16%
Kidney Function
16%
Prothrombin
16%
Blood Clotting
16%
Linear Regression Analysis
16%
Acetic Acid Derivative
16%
Kidney Injury
16%
Fibrinolysin
16%
Fibrinolysis
16%
Glucosaminidase
16%
Antiplasmin
16%
Kidney Concentrating Capacity
16%
Beta 2 Microglobulin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tissue Plasminogen Activator
100%
Hemolytic Uremic Syndrome
100%
Plasminogen Activator Inhibitor 1
50%
Diseases
33%
Infection
33%
D Dimer
33%
Escherichia Coli O157
33%
Kidney Injury
16%
Thrombin
16%
Thrombocytopenia
16%
Prothrombin
16%
Acetic Acid Derivative
16%
Plasmin
16%
Glucosaminidase
16%
Antiplasmin
16%
Beta 2 Microglobulin
16%